Viracta Therapeutics Inc. (VIRX)
undefined
undefined%
At close: undefined
0.20
-6.82%
After-hours Jan 03, 2025, 05:57 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Revenue n/a n/a n/a 120.00K 2.07M 237.00K 669.00K 2.54M 3.06M 5.73M 7.96M 3.75M 5.00M 33.08K 3.76M 5.42M 9.66M 13.71M 16.52M 10.30M
Cost of Revenue 492.00K 210.00K 178.00K 32.00K n/a -902.75K 9.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 10.30M
Gross Profit -492.00K -210.00K -178.00K 88.00K 2.07M 1.14M 660.00K 2.54M 3.06M 5.73M 7.96M 3.75M 5.00M 33.08K 3.76M 5.42M 9.66M 13.71M 16.52M n/a
Operating Income -50.69M -50.59M 62.50M -18.82M -23.29M -25.71M -34.42M -36.46M -39.30M -41.28M -31.68M -42.10M -19.84M -24.59M -40.22M -37.01M -38.55M -30.76M -26.82M -20.66M
Interest Income 3.35M 1.17M 38.00K 48.00K 472.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a 21.63M 929.00K 2.97M 3.40M 1.09B 517.64K
Pretax Income -51.06M -49.20M -114.76M -19.02M -23.33M -26.61M -35.46M -38.02M -36.68M -43.00M -34.60M -43.95M -20.14M -24.59M -63.24M -37.19M -40.11M -30.75M -26.81M -20.53M
Net Income -51.06M -49.77M -203.06M -19.20M -23.33M -26.61M -35.46M -38.02M -36.68M -44.72M -37.52M -45.81M -20.44M -24.59M -63.24M -37.36M -40.32M -31.23M -27.49M -20.53M
Selling & General & Admin 17.32M 24.33M 15.44M 5.35M 9.95M 11.32M 13.54M 16.10M 18.64M 23.11M 10.84M 9.18M 8.30M 7.00M 7.75M 11.52M 13.57M 12.25M 8.28M 5.18M
Research & Development 33.37M 26.26M 23.86M 13.47M 15.41M 14.62M 21.54M 22.88M 23.70M 27.66M 28.89M 29.18M 22.56M 14.43M 13.25M 26.29M 36.06M 35.62M 36.17M 23.62M
Other Expenses n/a 1.39M -13.50M -34.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.92B 1.92B 5.78M 1.56M n/a n/a n/a
Operating Expenses 50.69M 50.59M 25.80M 18.82M 25.36M 25.94M 35.08M 38.98M 42.34M 50.78M 39.73M 38.36M 30.87M 21.44M 21.00M 37.81M 49.63M 47.87M 44.45M 28.80M
Interest Expense 3.70M 577.00K 491.00K 216.00K 514.00K 1.15M 1.40M 1.72M 939.00K 1.72M 2.92M 1.85M 300.00K n/a 1.19K 171.31K 209.88K 477.64K 674.16K 386.75K
Selling & Marketing Expenses n/a n/a n/a n/a 9.95M 9.18M -9.00K -11.00K -27.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 50.69M 50.59M 25.80M 18.82M 25.36M 25.95M 35.09M 39.00M 42.36M 50.78M 39.73M 38.36M 30.87M 21.44M 21.00M 37.81M 49.63M 47.87M 44.45M 30.97M
Income Tax n/a 577.00K 88.30M 182.00K 514.00K 1.15M 1.40M 1.72M 939.00K 1.72M 2.92M 1.85M 300.00K -21.08B 1.19K 171.31K 209.88K 477.64K 674.16K n/a
Shares Outstanding (Basic) 38.62M 37.79M 31.87M 92.78K 2.49M 1.02M 700.46K 448.23K 347.30K 1.00M 870.82K 802.43K 773.53K 414.34K 95.52K 95.52K 89.83K 77.11K 63.80K 17.03K
Shares Outstanding (Diluted) 38.62M 37.79M 31.87M 92.78K 2.49M 1.02M 700.46K 448.23K 347.30K 1.03M 870.82K 802.43K 773.53K 414.34K 95.52K 95.52K 89.83K 77.11K 63.80K 17.03K
EPS (Basic) -1.32 -1.32 -6.37 -206.93 -9.37 -26.18 -50.62 -84.83 -105.6 -44.68 -43.08 -57.08 -26.43 -59.34 -662.05 -391.09 -448.8 -405.03 -430.85 -1.21K
EPS (Diluted) -1.32 -1.32 -6.37 -206.93 -9.37 -26.18 -50.62 -84.83 -105.6 -43.62 -43.08 -57.08 -26.43 -59.34 -662.05 -391.09 -448.8 -405.03 -430.85 -1.21K
EBITDA -46.86M -48.41M -114.09M -18.77M -22.82M -25.45M -34.05M -36.29M -35.71M -41.25M -31.66M -42.06M -20.09M -24.44M -39.88M -35.91M -36.82M -29.18M -25.14M -17.97M
Depreciation & Amortization 492.00K 210.00K 178.00K 32.00K 3.13K 9.00K 9.00K 11.00K 27.00K 29.00K 20.00K 31.00K 56.00K 150.23K 341.58K 1.10M 1.73M 1.58M 1.68M 2.17M